MSB Discussion 2022
- Thread starter zeeb0t
- Start date
is once again getting planned. Sit back enjoy the sun 
and the rain 🌧, as the season turn into summer. Hopefully its will be a great harvest 
for Mesoblast.
️
Learning
Learning to the Top 🕵♂️
Will this trading halt be an important milestone for Mesoblast?
I guess, we will find out Friday morning.
Not until we get the official announcement from Mesoblast, everything else, is just guess work.
I have been an investor in Mesoblast for 3 years, major of the duration are in the red. I believe in the sciences, and the efficiency of the products. With conviction, I was able to accumulate more MSB on the way down. The lowest was .68c. Yesterday, with conviction I accumulate another 1/3 to my holding. (Still 5% in the red).
What a beautiful winter day in Melbourne, especially the Trading Halt announcement.
Now, to sit back, and hope for a positive outcome for Mesoblast and the children requiring remestemcel-L for SR-aGVHD for their treatment. It's will be a new paradigm of medicine, first allogeneic (off-the-shelf) cellular medicines for the treatment
of severe and life-threatening inflammatory conditions.
Good luck to Mesoblast and its LTSH.
Learning 🏖
I guess, we will find out Friday morning.
Not until we get the official announcement from Mesoblast, everything else, is just guess work.
I have been an investor in Mesoblast for 3 years, major of the duration are in the red. I believe in the sciences, and the efficiency of the products. With conviction, I was able to accumulate more MSB on the way down. The lowest was .68c. Yesterday, with conviction I accumulate another 1/3 to my holding. (Still 5% in the red).
What a beautiful winter day in Melbourne, especially the Trading Halt announcement.
Now, to sit back, and hope for a positive outcome for Mesoblast and the children requiring remestemcel-L for SR-aGVHD for their treatment. It's will be a new paradigm of medicine, first allogeneic (off-the-shelf) cellular medicines for the treatment
of severe and life-threatening inflammatory conditions.
Good luck to Mesoblast and its LTSH.
Learning 🏖
Learning
Learning to the Top 🕵♂️
Wow, what a devastating day for all Mesoblast shareholders. The market cap, of a company just lost 56%; closed to 500 Millions was lost.
I am still confident as an investor, for Mesoblast will have remestemcel-L approve in the future.
Sometimes when you are in a dark tunnel looking for light;
I believe today conference call is worth a listen.
And have read from;
And
This is from Yahoo
finance.yahoo.com
Other
41m ago
"To be fair, are you saying that the potency assay has been rejected, or the manufacturing is sub par, or the long term efficacy is unproven ? If you are , you are wrong …the CRL requires further patient data in adults OR children. No doubt the FDA is concerned about giving approval to a paediatric therapy when all the doctors with a brain would use it off label for treatment refractory patients in adult. You do realise CavScout that around 45% of patients are refractory to the only approved adult therapy…mainly those with GI involvement. Meosblast have to cooperate with the FDA. They have to present the extra data. I suspect that they have more flexibility to partner now that CMC and manufacturing boxes have been ticked . A request for accelerated paediatric approval post funding and commencing of an adult trial is not off the table either . The FDA is playing hardball IMO"
Learning
Stay strong, money can be lost, money can be gain, but most important is your mental health.
I am still confident as an investor, for Mesoblast will have remestemcel-L approve in the future.
Sometimes when you are in a dark tunnel looking for light;
I believe today conference call is worth a listen.
And have read from;
https://hotcrapper.com.au/threads/the-fda-is-a-corrupt-organization.7510747/page-25
And
This is from Yahoo
Mesoblast Limited (MESO) Stock Forum & Discussion - Yahoo Finance
Find the latest Mesoblast Limited (MESO) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.
finance.yahoo.com
Other
41m ago
"To be fair, are you saying that the potency assay has been rejected, or the manufacturing is sub par, or the long term efficacy is unproven ? If you are , you are wrong …the CRL requires further patient data in adults OR children. No doubt the FDA is concerned about giving approval to a paediatric therapy when all the doctors with a brain would use it off label for treatment refractory patients in adult. You do realise CavScout that around 45% of patients are refractory to the only approved adult therapy…mainly those with GI involvement. Meosblast have to cooperate with the FDA. They have to present the extra data. I suspect that they have more flexibility to partner now that CMC and manufacturing boxes have been ticked . A request for accelerated paediatric approval post funding and commencing of an adult trial is not off the table either . The FDA is playing hardball IMO"
Learning
Stay strong, money can be lost, money can be gain, but most important is your mental health.
Learning
Learning to the Top 🕵♂️
Similar threads
